Transient effusive‐constrictive pericarditis due to chemotherapy
- 1 April 1999
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 22 (4) , 316-318
- https://doi.org/10.1002/clc.4960220414
Abstract
Commonly used chemotherapeutic agents, specifically cytarabine and daunorubicin, can cause effusive‐constrictive pericarditis. We describe a case of transient effusive‐constrictive pericarditis in a patient with acute myelogenous leukemia. This is the first case report of a patient with transient effusive‐constrictive pericarditis due to chemotherapy.Keywords
This publication has 7 references indexed in Scilit:
- Constrictive pericarditis after high-dose chemotherapyThe Lancet, 1997
- Pericarditis induced by high-dose cytosine arabinoside chemotherapyAnnals of Hematology, 1997
- Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapyLeukemia Research, 1995
- Pericarditis Associated with High-Dose Cytarabine Therapy for Acute Myeloblasts Leukemia: a Rare Complication of TherapyLeukemia & Lymphoma, 1992
- Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditisPublished by Elsevier ,1987
- Pericarditis induced by high-dose cytarabine therapyArchives of internal medicine (1960), 1984
- Subacute Effusive-Constrictive PericarditisCirculation, 1971